Stewart's frequent denials have failed to dispel the whiff of scandal that hangs over her business empire. The problems date back to a now notorious sale of shares in ImClone in December. She instructed her broker to sell 3,928 shares worth $227,000 (£151,000) on 27 December, the day before US regulators rejected the company's application for a cancer drug, sending the shares spiralling 84% lower.